Rays of Belief opens Rs 125cr IPO as 319-centre expansion puts profitability under scrutiny

Rays of Belief Limited, which operates the Mom’s Belief network for children with neurodevelopmental disorders, opened its ₹125 crore initial public offering on September 1 at a price band of ₹227 to ₹239 per share. The entirely fresh-share issue values the company at approximately ₹474 crore to ₹500 crore after the offering and is intended primarily to finance a dramatic expansion of its physical care network, which could grow from 136 Indian centres at March 31, 2026 to as many as 455 by FY29 if the planned 319 new locations are completed. Revenue from operations more than doubled to ₹81.66 crore in FY26 from ₹36.42 crore a year earlier, yet profit declined to about ₹4.96 crore from ₹5.88 crore, highlighting the difference between rapid service expansion and earnings growth. At the upper-band valuation, the company is entering the market at roughly 101 times FY26 post-issue earnings, making centre productivity, clinician availability and the economics of expansion much more important than the headline IPO size.

Why does the planned expansion from 136 to 455 centres define the Mom’s Belief IPO story?

Rays of Belief operated 136 Mom’s Belief centres across 57 cities and 20 states and union territories at March 31, including 42 centres in Tier 1 cities, 77 in Tier 2 markets and 17 in Tier 3 locations. The company says it has served more than 58,000 children since beginning commercial operations in 2018, while more than 2,500 children were actively enrolled across physical centres and digital programmes at the end of FY26. Its website currently identifies a workforce of 521 people, including about 340 clinicians.

The IPO is designed to accelerate that footprint substantially. Rays of Belief plans to establish 319 additional centres between FY27 and FY29, including 128 in Tier 1 cities, 121 in Tier 2 cities and 70 in Tier 3 markets. If all planned centres are additive to the existing network, the footprint would reach approximately 455 locations, representing growth of about 235% from the FY26 base and making the network roughly 3.35 times its current size.

That scale is commercially significant because neurodevelopmental intervention is not easily converted into a purely digital service. Children with autism spectrum disorder, ADHD, cerebral palsy, Down syndrome, learning disabilities and other developmental conditions can require occupational therapy, speech and language therapy, behavioural interventions, structured learning and family support delivered by trained professionals. Rays of Belief uses digital tools and home-based support, but physical centres and clinical professionals remain fundamental to its model.

The expansion therefore creates an opportunity and a constraint simultaneously. More centres can make services accessible to families outside major metropolitan areas, particularly in Tier 2 and Tier 3 cities where structured developmental-care capacity can be limited. However, each location also requires therapists, specialised staff, premises, equipment and enough children enrolled at economically sustainable utilisation levels.

How much of the ₹125 crore IPO is actually going toward building the new network?

Rays of Belief has allocated approximately ₹41.36 crore of IPO proceeds toward establishing new centres on leased premises and associated technology expenditure. Of that amount, about ₹34.99 crore is intended for centre fit-outs, ₹1.93 crore for therapy-material inventory and ₹4.44 crore for technology hardware. The expansion allocation therefore accounts for roughly one-third of the gross ₹125 crore issue.

Another ₹14.44 crore is earmarked for lease payments on existing centres in India, while ₹10.13 crore will be invested in subsidiary Mom’s Belief US Inc. for lease or licence payments associated with existing U.S. centres. Rays of Belief has also set aside ₹10.20 crore for brand awareness and inclusive outreach programmes, with the remaining permitted proceeds available for unidentified acquisitions and general corporate purposes.

The structure makes the IPO primarily a growth-capital transaction rather than an exit for existing shareholders. The entire 5.23 million-share offering is fresh equity, with no offer-for-sale component. That means the proceeds flow into Rays of Belief rather than directly to the promoter or other pre-IPO shareholders.

That alignment is positive, but it does not automatically make the expansion inexpensive. A substantial proportion of capital is supporting leased locations rather than owned real estate, and the business will need enough utilisation at each centre to cover recurring rent and clinical staffing after the IPO money has been deployed. Public investors are therefore financing not just expansion but the transition from a 136-centre operator into a much larger distributed healthcare-services network.

Can revenue growth above 120% offset the fact that FY26 profit actually declined?

Rays of Belief’s FY26 revenue trajectory is impressive. Consolidated revenue from operations increased to ₹81.66 crore from ₹36.42 crore in FY25, representing growth of approximately 124%. The company therefore added more revenue in a single year than its entire FY25 operating base.

Profit did not follow the same direction. FY26 profit declined to about ₹4.96 crore from ₹5.88 crore, a reduction of approximately 15.6%, even as revenue more than doubled. That movement suggests that expansion costs, staffing, leases, corporate infrastructure or other expenses grew sufficiently quickly to absorb the additional gross contribution from higher revenue.

The resulting FY26 net margin was only about 6.1%, based on profit of ₹4.96 crore and ₹81.66 crore of operating revenue. That is a Business News Today calculation using disclosed annual figures. The margin is not inherently weak for an expanding healthcare-services company, but the decline in absolute profit during a year of exceptional revenue growth means investors cannot assume that simply adding centres will automatically produce stronger earnings.

This is the central financial issue behind the IPO. Rays of Belief is preparing to increase its centre base by more than three times while current profit is moving in the opposite direction from revenue. If newly opened centres require a long ramp-up before reaching breakeven utilisation, the expansion could place further pressure on earnings before operating leverage eventually improves.

The strongest future signal would therefore be improving contribution margins at mature centres alongside faster breakeven at new ones. Without centre-level profitability disclosure, investors have limited visibility into how quickly the planned 319 locations can move from upfront investment to positive contribution.

Why does the ₹500 crore valuation create a demanding earnings hurdle for Rays of Belief?

At the upper price of ₹239, Rays of Belief is expected to have an implied post-issue market capitalisation of approximately ₹500 crore. Using FY26 profit of roughly ₹4.96 crore, that equates to about 101 times historical post-issue earnings. Market-data services similarly place the post-IPO earnings multiple around 100.8 times.

The same ₹500 crore valuation represents roughly 6.1 times FY26 revenue from operations. These Business News Today calculations use historical financial results and the estimated post-issue market capitalisation, so they are not forward-looking brokerage valuations. They simply illustrate how much future growth is already incorporated into the IPO pricing.

A high earnings multiple can be justified when profit is temporarily depressed by expansion and investors expect earnings to catch up rapidly. Rays of Belief has a plausible argument for that interpretation because FY26 revenue growth demonstrates meaningful demand and its centre network is still being built. The problem is that the planned expansion itself will require more spending before all of those centres mature.

Investors therefore need to decide whether FY26 profit represents a temporary low-margin growth phase or evidence that the service model becomes increasingly expensive as it scales. The difference could have a major impact on how quickly the current valuation multiple normalises.

If profit were to double while the market capitalisation remained unchanged, the historical earnings multiple would fall to around 50 times. If profit eventually quadrupled, it would approach 25 times. Those calculations illustrate the degree of earnings growth required before the valuation begins to resemble a more conventional healthcare-services multiple.

Could the pre-IPO placement pricing create questions around the final ₹227 to ₹239 price band?

Rays of Belief completed a ₹5.89 crore pre-IPO private placement before the public offering, and those shares were issued at prices of ₹284 and ₹290. The placement was subsequently adjusted against the fresh issue, reducing the public offer from the 6 million shares contemplated in earlier draft documents to approximately 5.23 million shares.

The final IPO price band of ₹227 to ₹239 is therefore below the prices paid in those pre-IPO placements. At the top of the public range, ₹239 is approximately 15.8% below ₹284 and 17.6% below ₹290. The comparison does not automatically mean the IPO is cheap because pre-IPO placement terms, timing, investor rights and capital structure can differ from a public issue.

It does, however, show that the valuation framework changed between the private placement and the final offer. Public investors are being offered shares at a lower nominal price than those recent pre-IPO investors, while the company still secures enough capital to fund its planned expansion programme.

That may help explain the retail attention surrounding the issue. By 11:50 a.m. on September 1, the IPO had received bids equal to approximately 52% of the shares available to public investors, while the retail category was subscribed about 2.87 times. Institutional participation was still limited at that early stage, and the book remains open through September 3, so first-day subscription should not be treated as a final indication of institutional valuation support.

Why is clinician availability one of the biggest operational constraints on a 319-centre expansion?

Healthcare-services businesses cannot scale merely by opening locations. Rays of Belief’s services depend on child psychologists, speech-language pathologists, occupational therapists, special educators, behaviour therapists and other clinical professionals capable of working with children requiring personalised developmental interventions. The company itself identifies recruitment and retention of qualified personnel as a material factor affecting its operations.

The constraint can become more severe outside major metropolitan areas. Rays of Belief’s filing materials note that the availability of appropriately trained professionals varies considerably by geography, particularly in Tier 3 markets. When qualified staff are unavailable locally, the company may need to relocate professionals, alter service availability or bear higher operating costs.

That matters because 191 of the 319 proposed new centres are planned for Tier 2 and Tier 3 markets. The expansion is strategically attractive precisely because those areas can be underserved, but the same undersupply of services can reflect a shortage of trained professionals capable of delivering them.

Rays of Belief therefore needs to scale its workforce almost alongside its physical footprint. Training, clinical supervision, staff retention and standardisation of treatment quality will become increasingly important as the network moves from 136 centres toward several hundred.

This is also where digital systems may provide economic leverage. Centralised assessment tools, parent-support programmes, digital follow-ups and standardised clinical protocols can allow specialist expertise to support a wider geographic network. Technology can improve productivity, but it cannot entirely remove the need for qualified therapists delivering physical interventions at local centres.

Does expansion into the United States improve the growth story or make the model more complicated?

Rays of Belief is already moving beyond India through Mom’s Belief US Inc., with the IPO allocating ₹10.13 crore toward lease or licence payments for existing U.S. centres. The company has also indicated longer-term international ambitions that could include the United Arab Emirates and the United Kingdom.

International expansion provides an obvious revenue opportunity because developmental and behavioural therapy markets in the United States can support substantially higher pricing than Indian markets. The company could also potentially use expertise developed across a large Indian clinical network to build specialised programmes internationally.

However, the operating model becomes more complex when it crosses borders. Healthcare professional licensing, reimbursement structures, clinical documentation, privacy requirements and labour costs can differ substantially from India. A strategy that works through relatively small leased centres in Indian Tier 2 cities may not generate the same economics in U.S. metropolitan markets.

The IPO therefore exposes investors to two expansion programmes at once. Rays of Belief is attempting a massive domestic rollout while simultaneously funding an international subsidiary. Maintaining execution discipline across both will be important because international expansion can consume management attention and cash long before it becomes material to consolidated earnings.

Can Mom’s Belief convert an underserved healthcare need into scalable commercial economics?

The demand case behind Rays of Belief is stronger than the economics have yet proven. Awareness of autism, ADHD, learning disabilities and developmental delays has increased, while more parents are seeking early assessment and structured intervention. In many Indian cities, particularly outside the largest metros, families can still struggle to locate multidisciplinary developmental services in one organised network.

Mom’s Belief is attempting to formalise that fragmented market. Its model combines centre-based intervention with parental guidance and digital programmes, allowing families to participate in therapy outside formal clinical sessions. The company describes this parent-as-co-therapist approach as part of its effort to improve accessibility and affordability.

Scale can create advantages in training, clinical protocols, branding and procurement of therapy materials. A larger network can also allow the company to build referral relationships with paediatricians, schools and other healthcare professionals while creating brand recognition among parents.

Yet healthcare scale must be measured differently from retail scale. A new store can sell the same products as every other location, but developmental-care outcomes depend heavily on the quality and consistency of individual professionals. Expanding to 455 centres while preserving care standards could therefore be substantially harder than the physical rollout number suggests.

The commercial opportunity is real, but the company must show that accessibility, clinical quality and shareholder returns can improve together rather than one being sacrificed for another.

What are the key takeaways from the Rays of Belief and Mom’s Belief IPO?

• Rays of Belief opened its ₹125 crore IPO on September 1 at ₹227 to ₹239 per share, with the offer scheduled to close on September 3.
• The transaction consists entirely of fresh shares and has no offer-for-sale component.
• The upper end of the price band implies a post-issue market capitalisation of approximately ₹500 crore.
• Rays of Belief operated 136 Mom’s Belief centres across 57 cities and 20 states and union territories at March 31, 2026.
• Management plans to establish 319 additional centres through FY29, potentially taking the network to approximately 455 locations.
• FY26 operating revenue more than doubled to ₹81.66 crore, but profit declined to approximately ₹4.96 crore from ₹5.88 crore.
• The upper-band valuation implies a historical post-issue earnings multiple of roughly 101 times and a revenue multiple of approximately 6.1 times on Business News Today calculations.
• Around ₹41.36 crore of proceeds is earmarked for new centres and related equipment, while additional capital will support Indian leases, U.S. operations and marketing.
• The company completed a pre-IPO placement at ₹284 to ₹290 per share, above the final ₹227 to ₹239 public price band.
• The largest execution risks are clinician availability, new-centre utilisation, maintaining care quality and converting rapid revenue growth into sustained profit growth.

What would show that the 319-centre expansion is actually creating value for shareholders?

Rays of Belief is entering public markets with a compelling social and commercial proposition. It operates in a healthcare segment where demand is expanding, access remains fragmented and families increasingly seek structured intervention for children with developmental needs. The company has also demonstrated that it can grow revenue quickly, more than doubling operating revenue during FY26 while building a nationwide network.

The IPO valuation nevertheless asks investors to look well beyond current earnings. A roughly ₹500 crore market capitalisation against approximately ₹4.96 crore of FY26 profit means the company needs substantial earnings growth before conventional valuation metrics become comfortable. That growth cannot come simply from opening centres because FY26 already demonstrated that revenue expansion and profit expansion can diverge.

The strongest post-listing evidence would be rising utilisation at mature centres, declining time to breakeven for newly opened locations and improving consolidated net margins while the clinical workforce expands. If revenue continues growing rapidly and profit begins increasing faster than fixed costs, the 319-centre programme could create meaningful operating leverage.

The thesis would weaken if clinician shortages slow openings, if new centres require sustained subsidies, if international expansion absorbs disproportionate capital or if profit remains near current levels despite a much larger network. A company can become India’s largest organised provider in its category without necessarily producing attractive returns if the economics of each additional centre are weak.

Mom’s Belief therefore presents an unusual IPO proposition. Public shareholders are not merely financing another network of healthcare locations. They are financing an attempt to industrialise and standardise a highly people-intensive form of developmental care across hundreds of Indian cities.

The company has already shown that demand exists. The next test is whether 455 centres can become a substantially more profitable business than 136.